Inhibition of human ovarian tumor growth by cytokine-induced killer cells

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Archives of pharmacal research

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02977372PMID 18087816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokine-activated killer cells.

  2007cited by this paper
• Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.

  2007cited by this paper
• Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.

  2007cited by this paper
• Angelan isolated from Angelica gigas Nakai induces dendritic cell maturation through toll-like receptor 4.

  2007cited by this paper
• Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study

  2006cited by this paper
• Synergistic Antitumor Effects of Immune Cell-Viral Biotherapy

  2006cited by this paper
• Human T Cells Armed with Her2/neu Bispecific Antibodies Divide, Are Cytotoxic, and Secrete Cytokines with Repeated Stimulation

  2006cited by this paper
• Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1.

  2006cited by this paper
• Cytokine‐induced killer cells against autologous CLL: Direct cytotoxic effects and induction of immune accessory molecules by interferon‐γ

  2006cited by this paper
• [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].

  2006cited by this paper
• Tracking of green fluorescent protein (GFP)-labeled LAK cells in mice carrying B16 melanoma metastases.

  2006cited by this paper
• Helper roles of NK and CD8+ T cells in the induction of tumor immunity

  2006cited by this paper
• [Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].

  2006cited by this paper
• Ovarian cancer incidence and survival in Korea: 1993–2002

  2006cited by this paper
• Silencing Human NKG2D, DAP10, and DAP12 Reduces Cytotoxicity of Activated CD8+ T Cells and NK Cells1

  2005cited by this paper
• Low Levels of Her2/neu Expressed by Ewing's Family Tumor Cell Lines Can Redirect Cytokine-Induced Killer Cells

  2005cited by this paper
• Studies on Inducing Apoptosis Effects and Mechanism of CIK Cells for MGC-803 Gastric Cancer Cell Lines

  2005cited by this paper
• Effective prevention of lethal acute graft-versus-host disease by combined immunosuppressive therapy with prodigiosin and cyclosporine A.

  2005cited by this paper
• Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.

  2005cited by this paper
• A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.

  2005cited by this paper
• Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles.

  2005cited by this paper
• Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

  2004cited by this paper
• Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

  2003cited by this paper
• Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation.

  2001cited by this paper
• Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.

  2001influential reference
• 5-Aza-2'-deoxycytidine leads to down-regulation of aberrant p16INK4A RNA transcripts and restores the functional retinoblastoma protein pathway in hepatocellular carcinoma cell lines.

  2000cited by this paper
• Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

  2000influential reference
• The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis.

  1999cited by this paper
• A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

  1994cited by this paper
• Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

  1991cited by this paper

• Advances in the treatment of malignant ascites in China

  2024cites this paper
• Development of PD-1 blockade peptide-cell conjugates to enhance cellular therapies for T-cell acute lymphoblastic leukemia

  2023cites this paper
• Rise of the natural red pigment ‘prodigiosin’ as an immunomodulator in cancer

  2022cites this paper
• Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer

  2020cites this paper
• Ovarian Cancer Immunotherapy: Turning up the Heat

  2019cites this paper
• Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer

  2019cites this paper
• The long-term efficacy of cytokine-induced killer cellular therapy for hepatocellular carcinoma: a meta-analysis.

  2019cites this paper
• Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer

  2019cites this paper
• Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers

  2018cites this paper
• Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

  2018cites this paper
• Restoration of CD3+CD56+ cell level improves skin lesions in severe psoriasis: A pilot clinical study of adoptive immunotherapy for patients with psoriasis using autologous cytokine-induced killer cells.

  2018cites this paper
• Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas.

  2017cites this paper
• Cancer Immunotherapy with Cytokine-Induced Killer Cells

  2017cites this paper
• The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancer

  2017cites this paper
• Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model

  2017cites this paper
• Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial

  2016cites this paper
• Adoptive immunotherapy against ovarian cancer

  2016cites this paper
• Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives.

  2016cites this paper
• Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)

  2015cites this paper
• Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells

  2015cites this paper
• Cytokine-Induced Killer Cells Engineered with Exogenous T-Cell Receptors Directed Against Melanoma Antigens: Enhanced Efficacy of Effector Cells Endowed with a Double Mechanism of Tumor Recognition

  2015cites this paper
• Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.

  2015cites this paper
• Lipid-Soluble Ginseng Extract Inhibits Invasion and Metastasis of B16F10 Melanoma Cells

  2015cites this paper
• The Function of CD 3 + CD 56 + NKT-Like Cells in HIV-Infected Individuals

  2015cites this paper
• Maintenance Therapy With Autologous Cytokine-induced Killer Cells in Patients With Advanced Epithelial Ovarian Cancer After First-line Treatment

  2014cites this paper
• Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: a systematic review and meta-analysis.

  2014cites this paper
• Effects of cytokine-induced killer cell treatment in colorectal cancer patients: a retrospective study.

  2014cites this paper
• A killer choice for cancer immunotherapy

  2014cites this paper
• The Function of CD3+CD56+ NKT-Like Cells in HIV-Infected Individuals

  2014cites this paper
• Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma

  2014cites this paper
• Effects of two different immunotherapies on triple negative breast cancer in animal model.

  2013cites this paper
• Immunotherapy with Cytokine-Induced Killer Cells as an Adjuvant Treatment for Advanced Gastric Carcinoma: A Retrospective Study of 165 Patients

  2013cites this paper
• The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study

  2012cites this paper
• Inhibition of Human Pancreatic Tumor Growth by Cytokine-Induced Killer Cells in Nude Mouse Xenograft Model

  2012cites this paper
• Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models

  2012cites this paper
• Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors

  2012cites this paper
• Emergence of peripheral CD3+CD56+ cytokine-induced killer cell in HIV-1-infected Chinese children.

  2012cites this paper
• Anticancer Effect of Activated Natural Killer Cells on Human Non-small Cell Lung Cancer

  2011cites this paper
• Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: more than one plus one?

  2011cites this paper
• Establishment, Characterization, and Successful Adaptive Therapy against Human Tumors of NKG Cell, a New Human NK Cell Line

  2011cites this paper
• Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells

  2010cites this paper
• Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

  2010cites this paper
• A Lipid-Soluble Red Ginseng Extract Inhibits the Growth of Human Lung Tumor Xenografts in Nude Mice

  2010cites this paper
• Experimental approaches for the treatment of malignant gliomas.

  2010cites this paper
• Growth of Human Colorectal Cancer SW1116 Cells Is Inhibited by Cytokine-Induced Killer Cells

  2010cites this paper
• 重组人纤维连接蛋白诱导的CIK细胞的生物学特性和对肺癌细胞株杀伤活性的体外研究

  2010cites this paper
• Synergistic therapeutic effects of cytokine-induced killer cells and temozolomide against glioblastoma.

  2010cites this paper
• A lipid-soluble ginseng extract inhibits human large cell lung cancer (NCI-H460) cells xenograft In Vivo and the proliferation of cancer cells In Vitro

  2010cites this paper
• Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.

  2009cites this paper
• Synergistic cytotoxicity of interferonalpha-2b and interleukin-2 in combination with PBMC against ovarian cancer: development of an experimental model for cellular therapy.

  2009cites this paper
• Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model.

  2009cites this paper
• Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model

  2009cites this paper
• Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.

  2008cites this paper